×

Concerned about your own or
someone else’s drug use?

NCCRED Clinical Research Seed Funding

Risk communication for people who use illicit drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts

Amount Awarded: $96,120.00

Principal Investigator: Dr Amy Peacock, University of New South Wales

Risk communication for people who use illicit drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts

Amount Awarded: $96,120.00

Principal Investigator: Dr Amy Peacock, University of New South Wales

Due to the unregulated nature of the illicit drug market, consumers are often unaware of substance contents1. Some public health agencies and other organisations disseminate ‘drug alerts’ (i.e., communication about significant unique or pervasive health risks of a specific substance) to increase consumer awareness of risk of harm and promote harm reduction behaviour. However, there is a distinct lack of research regarding consumer preferences for communication of these alerts, as well as potential intended and unintended behavioural responses. Previous research has concentrated on people who inject drugs, with little consideration of heterogeneity between consumers of illicit drugs and of theory underpinning risk communication, and with little exploration of preferences regarding language, content and communication mode.

The aims of this study are to develop practical guidance for stakeholders communicating drug alerts to people who use Millicit drugs. Specifically, we will examine:

Consumer preferences for communication of drug alerts for:

  • Language;
  • Content;
  • Timeliness; andCommunication mode.

Anticipated intended and unintended responses to drug alerts (i.e., awareness of risk of harm and behavioural responses) under scenarios of different content information about:

  • Substance characteristics;
  • Substance effects; and
  • Harm reduction messaging.

The latter aim will include exploration of factors associated with differential responses to drug alerts (e.g., risk perception style of recipient).

Through partnerships between researchers, consumers, clinicians and other stakeholders, we will achieve the development of guidance by:

1. Data collection: Gathering data via an online survey (n=~1,000) on consumer communication preferences and potential behavioural responses to drug alerts;

2. Data synthesis: Synthesising survey results, existing evidence, international guidance and case reports of outcomes of previous drug alerts to prepare a draft guidance document;

3. Guidance evaluation: Reviewing this draft guidance with two reference groups involving i) stakeholders communicating alerts, and ii) consumers; and

4. Guidance dissemination and translation: Actively promoting guidance (e.g., through a report, webinar, conference workshop, social media) with those responsible for communication of drug alerts.

This guidance will facilitate timely, consistent, and evidence-based messaging of drug alerts to reduce risk of drug-related harm, including informing communication through NCCRED’s Prompt Response Network (PRN) and other communication channels.

Specifically, we will examine:

1. Consumer awareness of and responses to existing alerts.

2. Consumer preferences for communication of drug alerts for:

    • Language;
    • Content;
    • Timeliness; and
    • Communication mode

3. Anticipated intended and unintended responses to drug alerts (i.e., awareness of risk of harm and behavioural responses) under scenarios of different content information about:

    • Substance characteristics;
    • Substance effects; and
    • Harm reduction messaging.

Dr Amy Peacock, Chief Investigator

National Drug and Alcohol Research Centre, UNSW

Dr Rachel Sutherland, Chief Investigator

National Drug and Alcohol Research Centre, UNSW

A/Prof Raimondo Bruno, Chief Investigator

School of Medicine (Psychology), University of Tasmania

Dr Monica Barratt, Chief Investigator

Social and Global Studies Centre, RMIT University

Dr Mary Ellen Harrod, Chief Investigator

NSW Users and AIDS Association (NUAA)

Mr Gulliver McLean, Chief Investigator

NSW Users and AIDS Association (NUAA)

Prof Harry Sumnall, Chief Investigator

Public Health Institute, Liverpool John Moores University

Mr Robin Auld, Chief Investigator

Centre for Population Health, NSW Ministry of Health

Mr Jared Brown, Chief Investigator

Centre for Population Health, NSW Ministry of Health

Dr Robert Page, Chief Investigator

Kirketon Road Centre / St Vincent’s Hospital

Ms Penny Hill, Chief Investigator

NCCRED

A/Prof Nadine Ezard, Chief Investigator

NCCRED / St Vincent’s Hospital

Ms Greta Baillie

National Drug and Alcohol Research Centre, UNSW